#United States #Indianapolis #Healthcare Conference #Eli Lilly #Wells Fargo

Eli Lilly to Join the 20th Annual Wells Fargo Healthcare Conference

Eli Lilly and Company, a prominent name in the pharmaceutical industry, is gearing up for its participation in the highly anticipated Wells Fargo 20th Annual Healthcare Conference. Scheduled for September 5, 2025, this event will serve as a platform for showcasing the latest advancements and trends in healthcare.

In an exciting development, Patrik Jonsson, the executive vice president and president of Lilly International, is set to engage in a fireside chat that will commence at 9:30 a.m. Eastern Time. This dialogue promises insights into the company's strategic vision and ongoing commitment to enhancing patient care through innovative solutions.

Those interested in the proceedings will have the opportunity to tune in via a live audio webcast. This will be accessible through the "Webcasts & Presentations" section of Lilly's investor website. After the event, a replay of the discussion will be made available for about 90 days, ensuring that those unable to attend in real-time can still benefit from the knowledge shared during the conference.

About Eli Lilly and Company

Founded nearly 150 years ago, Eli Lilly aims to make life better for people worldwide through its pioneering work in medicine. The company has made substantial contributions to healthcare, impacting the lives of tens of millions across the globe. Utilizing a mix of biotechnology, chemistry, and genetic medicine, Lilly's scientists are intensely focused on addressing some of the most pressing health challenges faced today.

Their diverse portfolio includes redefining diabetes care, tackling obesity and its long-term effects, advancing treatment for Alzheimer’s disease, providing solutions for immune system disorders, and transforming difficult-to-treat cancers into manageable conditions. This ongoing pursuit reflects Lilly's vision to ensure that their innovations not only advance medicine but are also accessible and affordable to all.

Commitment to Diversity and Accessibility

As part of its mission, Eli Lilly emphasizes the importance of diversity in clinical trials, recognizing that health solutions must resonate with the diverse populations they serve. The organization leverages various platforms to ensure that their medicines are not only ground-breaking but also reach a wide array of patients who need them most.

For those eager to learn more about Eli Lilly's initiatives or to follow their updates, additional information is readily available at Lilly.com and their news portal Lilly.com/news. Furthermore, followers can stay connected through their social media channels, including Facebook, Instagram, and LinkedIn.

In conclusion, Eli Lilly’s participation in the Wells Fargo Healthcare Conference highlights its ongoing commitment to innovation in healthcare, and its commitment to enhancing patient lives through transformative solutions. As the healthcare landscape continues to evolve, Lilly remains at the forefront, dedicated to making significant contributions that ultimately lead to better health outcomes for people around the world.